CHRISTINA OLDHAM: Open Payments
NPI 1154833879 · BENTON HARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,303 in 70 payments from 12 companies in 2025. Trend: 2023 $1,780 · 2024 $1,786 · 2025 $1,303
Food & beverage: $1,303
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 29 | $583 |
| E.R. Squibb & Sons, L.L.C. | 18 | $282 |
| Vanda Pharmaceuticals Inc. | 5 | $108 |
| ABBVIE INC. | 4 | $72 |
| Janssen Pharmaceuticals, Inc | 3 | $68 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Alkermes, Inc. | 1 | $20 |
Products named: INGREZZA, COBENFY, FANAPT, VRAYLAR, REXULTI, Qelbree, Auvelity, INVEGA SUSTENNA.
Industry payments across MI — which companies pay providers there.
